WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	201.56B
Revenue (ttm)	39.59B
Net Income (ttm)	11.18B
Shares Out	2.85B
EPS (ttm)	3.24
PE Ratio	18.63
Forward PE	16.51
Dividend	0.98 (1.39%)
Ex-Dividend Date	May 21, 2025

Volume	21,639,665
Average Volume	29,981,753
Open	69.39
Previous Close	70.40
Day's Range	68.90 - 70.98
52-Week Range	36.36 - 71.65
Beta	0.76
RSI	63.98
Earnings Date	Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.